Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
7 studies found for:    assurerx
Show Display Options
Rank Status Study
1 Completed Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical Setting
Condition: Major Depressive Disorder
Intervention: Genetic: Genotyping results
2 Recruiting A PK/PD Genetic Variation Treatment Algorithm Versus Treatment As Usual for Adolescent Management Of Depression
Condition: Depression
Interventions: Other: AssureRx GeneSight genotyping results;   Other: Treatment as usual
3 Recruiting A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management Of Depression
Conditions: Depression;   Mood Disorder;   Bipolar
Interventions: Other: AssureRx GeneSight genotyping results;   Other: Treatment as usual
4 Completed Pharmacogenetic-Directed Treatment for Major Depression
Condition: Depression
Interventions: Behavioral: GeneSightRx;   Behavioral: Treatment as usual
5 Active, not recruiting Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From a Major Depressive Disorder (MDD) and Having Had an Inadequate Response to at Least One Psychotropic Medication Included in GeneSight Psychotropic
Condition: Major Depressive Disorder (MDD)
Intervention: Genetic: GeneSight Psychotropic
6 Recruiting Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Schizophrenia/Schizoaffective Disorder
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Genetic: GeneSight Psychotropic (GEN);   Genetic: Enhanced-GeneSight Psychotropic (E-GEN);   Other: Treatment as Usual (TAU)
7 Recruiting Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder
Conditions: Depressive Disorder, Major;   Depression;   Depressive Disorder
Interventions: Genetic: GeneSight Psychotropic (GEN);   Genetic: Enhanced-GeneSight Psychotropic (E-GEN);   Other: Treatment as Usual (TAU)

Study has passed its completion date and status has not been verified in more than two years.